Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
1,459,524
-
Shares change
-
+488,171
-
Total reported value, excl. options
-
$44,254,889
-
Value change
-
+$14,757,407
-
Put/Call ratio
-
28%
-
Number of buys
-
10
-
Number of sells
-
22
-
Price
-
$30.38
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2022
As of 31 Dec 2022 ALPS ETF TR - MED BREAKTHGH (SBIO) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,459,524 shares of stock of the company.
Largest 10 holders included DAVENPORT & Co LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., Royal Bank of Canada, NTV Asset Management LLC, Beacon Pointe Advisors, LLC, Strategic Financial Services, Inc,, and CITADEL ADVISORS LLC.
This table shows 45 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.